Abiraterone switches castration‐resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling
J. Matthijs Moll, Johannes Hofland, Wilma Teubel, Corina M.A. De Ridder, Angela Taylor, Ralph Graeser, Wiebke Arlt, Guido Jenster, Wytske Van Weerden
Research output: Contribution to journal › Article › peer-review
53Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Abiraterone switches castration‐resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling'. Together they form a unique fingerprint.